High speed phenotypic profiling with AI enabled imaging

Traditional imaging platforms are often constrained by sluggish acquisition speeds, low signal-to-background ratios, and inefficient data administration, which reduces their usefulness in high-throughput screening.

Image Credit: Molecular Devices

Image Credit: Molecular Devices

Molecular Devices developed the ImageXpress® HCS.ai High-Content Screening System to address these restrictions, which features completely new hardware and software.

Improvements to x, y, and z stage movement and autofocus versatility result in increased throughput. The new cutting-edge optical light path, which includes optimized light sources and a higher quantum efficiency camera, means shorter exposure times, less background, and a better signal-to-noise ratio.

This scientific poster presents three test examples that show how the HCS.ai system's intuitive software interface facilitates a smooth and efficient workflow from setup to analysis.

Download the Poster

About Molecular Devices UK Ltd

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Jun 18, 2026 at 2:26 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Molecular Devices UK Ltd. (2026, June 18). High speed phenotypic profiling with AI enabled imaging. News-Medical. Retrieved on June 24, 2026 from https://www.news-medical.net/whitepaper/20250605/High-speed-phenotypic-profiling-with-AI-enabled-imaging.aspx.

  • MLA

    Molecular Devices UK Ltd. "High speed phenotypic profiling with AI enabled imaging". News-Medical. 24 June 2026. <https://www.news-medical.net/whitepaper/20250605/High-speed-phenotypic-profiling-with-AI-enabled-imaging.aspx>.

  • Chicago

    Molecular Devices UK Ltd. "High speed phenotypic profiling with AI enabled imaging". News-Medical. https://www.news-medical.net/whitepaper/20250605/High-speed-phenotypic-profiling-with-AI-enabled-imaging.aspx. (accessed June 24, 2026).

  • Harvard

    Molecular Devices UK Ltd. 2026. High speed phenotypic profiling with AI enabled imaging. News-Medical, viewed 24 June 2026, https://www.news-medical.net/whitepaper/20250605/High-speed-phenotypic-profiling-with-AI-enabled-imaging.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.